Pre-radiation targeted therapy for highly selected patients with newly diagnosed glioblastoma: New tricks for an old dog?
Neuro Oncol
.
2025 May 15;27(4):897-899.
doi: 10.1093/neuonc/noaf014.
Authors
Macarena I de la Fuente
1
2
,
Andrew B Lassman
3
4
Affiliations
1
Department of Neurology, University of Miami, Miami, Florida, USA.
2
Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA.
3
Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians & Surgeons, New York, New York, USA.
4
Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
PMID:
39851167
DOI:
10.1093/neuonc/noaf014
No abstract available
Publication types
Editorial
Comment
Grants and funding
5P30CA240139-04/The Sylvester Comprehensive Cancer Center
The Dowskin Family Foundation
2UM1-CA186644-06, 1R37CA262510-01A1 and1R21CA282543/NH/NIH HHS/United States
The William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma at NewYork-Presbyterian Hospital
Hearst Foundations
The Michael Weiner Glioblastoma Research into Treatment Fund
P30CA013696/Herbert Irving Comprehensive Cancer Center Support Grant
UL1TR001873/TR/NCATS NIH HHS/United States